Neoadjuvant chemotherapy in Stage IB2 squamous cell carcinoma of the cervix

Gynecologic Oncology

Volumn 65, Issue 2, 1997, Pages 348-356

  Serur, Eli ^a,b   Mathews, Roland P ^a   Gates, Jason ^a   Levine, Phyllis ^a   Maiman, Mitchell ^a   Remy, Jean Claude ^a  

^a SUNY DOWNSTATE MEDICAL CENTER   (United States)

^b BROOKLYN HOSPITAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CISPLATIN; METHOTREXATE; VINCRISTINE;

ADULT; AGED; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; FEMALE; HUMAN; PRIORITY JOURNAL; TREATMENT OUTCOME; UTERINE CERVIX CARCINOMA;

EID: 0031149752     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1997.4645     Document Type: Article

References (30)

1. Hoskins W J, Ford J H Jr, Lutz M H, Averette H E. Radical hysterectomy and pelvic lymphadenectomy for the management of early invasive carcinoma of the cervix. Gynecol Oncol. 4:1976;278-290.
2. Delgado G, Bundy B N, Fowler W C, Stehman F B, Sevin B, Creasman W T, Major F, DiSaia P, Zaino R. A prospective surgical pathological staging of stage I squamous carcinoma of the cervix: a Gynecologic Oncology Group Study. Gynecol Oncol. 35:1989;314-320.
3. Alvarez R D, Soong S J, Kinney W K, Reid G C, Schray M F, Podratz K C, Morley G W, Shingleton H M. Identification of prognostic factors and risk groups in patients found to have nodal metastasis at the time of radical hysterectomy for early-stage squamous carcinoma of the cervix. Gynecol Oncol. 35:1989;130-135.
4. Perez C A, Grigsby P W, Nene S M, Camel H M, Galakatos A, Kao M S, Lockett M A. Effect of tumor size on the prognosis of carcinoma of the uterine cervix treated with irradiation alone. Cancer. 69:1992;2796-2806.
5. Thoms W W, Eifel P J, Smith T L, Morris M, Delclos L, Wharton J T, Oswald M J. Bulky endocervical carcinoma: a 23-year experience. Int J Radiat Oncol Biol Phys. 23:1992;491-499.
6. Chung C K, Nahhas W A, Stryker J A, Curry S L, Abt A B, Mortel R. Analysis of factors contributing to treatment failures in Stage IB and IIA carcinoma of the cervix. Am J Obstet Gynecol. 138:1980;550-556.
7. Gallion H H, van Nagell J R Jr, Donaldson E S, Hanson M B, Powell D E, Maruyama Y, Yoneda J. Combined radiation therapy and extra-fascial hysterectomy in the treatment of stage IB barrel-shaped cervical cancer. Cancer. 56:1985;262-265.
8. Finan M A, DeCesare S, Fiorica J V, Chambers R, Hoffman M S, Kline R C, Roberts W S, Cavanagh D. Radical hysterectomy for stage IB1 vs IB2 carcinoma of the cervix: does the new staging system predict morbidity and survival? Gynecol Oncol. 62:1996;139-147.
9. Jones W B. New approaches to high-risk cervical cancer: advanced cervical cancer. Cancer. 71:1993;1451-1459.
10. Warren S. The grading of carcinoma of the cervix uteri as checked at autopsy. Arch Pathol. 12:1931;783-786.
11. Cox D R. Regression models and life tables. J Roy Stat Soc Ser B. 34:1972;187-202.
12. Sardi J, Sananes C, Giaroli A, Bayo J, Rueda N G, Vighi S, Guardado N, Paniceres G, Snaidas L, Vico C, Di Paola G. Results of a prospective randomized trial with neoadjuvant chemotherapy in Stage IB, bulky, squamous carcinoma of the cervix. Gynecol Oncol. 49:1993;156-165.
13. Friedlander M L, Atkinson K, Coppleson J V, Elliot P, Green D, Houghton R, Solomon H J, Russell P, Tattersall M H. The integration of chemotherapy into the management of locally advanced cervical cancer: a pilot study. Gynecol Oncol. 19:1984;1-7.
14. Kim D S, Moon H, Hwang Y Y, Cho S H. Preoperative adjuvant chemotherapy in the treatment of cervical cancer stage Ib, IIa, and IIb with bulky tumor. Gynecol Oncol. 29:1988;321-332.
15. Dottino P R, Plaxe S C, Beddoe A M, Johnston C, Cohen C J. Induction chemotherapy followed by radical surgery in cervical cancer. Gynecol Oncol. 40:1991;7-11.
16. Benedetti Panici P, Scambia G, Baiocchi G, Greggi S, Ragusa G, Gallo A, Conte M, Battaglia F, Laurelli G, Rabitti C, Capelli A, Mancuso S. Neoadjuvant chemotherapy and radical surgery in locally advanced cervical cancer. Prognostic factors for response and survival. Cancer. 67:1991;372-379.
17. Sardi J, Sananes C, Giaroli A, Maya G, di Paola G. Neoadjuvant chemotherapy in locally advanced carcinoma of the cervix uteri. Gynecol Oncol. 38:1990;486-493.
18. Namkoong S E, Park J S, Kim J W, Bae S N, Han G T, Lee J M, Jung J K, Kim S J. Comparative study of the patients with locally advanced stages I and II cervical cancer treated by radical surgery with and without preoperative adjuvant chemotherapy. Gynecol Oncol. 59:1995;136-142.
19. Eddy G L, Manetta A, Alvarex R D, Williams L, Creasman W T. Neoadjuvant chemotherapy with vincristine and cisplatin followed by radical hysterectomy and pelvic lymphadenectomy for FIGO stage IB bulky cervical cancer: a Gynecologic Oncology Group pilot study. Gynecol Oncol. 57:1995;412-416.
20. Bolis G, van Zainten-Przybysz I, Scarfone G, Zanaboni F, Scarabelli C, Tateo S, Calabrese M, Parazzini F. Determinants of response to a cisplatin-based refimen as neoadjuvant chemotherapy in Stage IB-IIB invasive cervical cancer. Gynecol Oncol. 63:1996;62-65.
21. Webb M J, Symmonds R E. Site of recurrence of cervical cancer after radical hysterectomy. Am J Obstet Gynecol. 138:1980;813-817.
22. Krebs H B, Helmkamp B F, Sevin B U, Poliakoff S R. Recurrent cancer of the cervix following radical hysterectomy and pelvic node dissection. Obstet Gynecol. 59:1982;422-427.
23. Potter M E, Alvarez R D, Shingleton H M, Soong S J, Hatch K D. Early invasive cervical cancer with pelvic lymph node involvement: to complete or not to complete radical hysterectomy? Gynecol Oncol. 37:1990;78-81.
24. Lovecchio J L, Averette H E, Donato D, Bell J. 5-year survival of patients with periaortic nodal metastases in clinical stage IB and IIA cervical carcinoma. Gynecol Oncol. 34:1989;43-45.
25. Podczaski E S, Stryker J A, Kaminski P, Ndubisi B, Larson J, DeGeest K. Extended-field radiation therapy for carcinoma of the cervix. Cancer. 66:1990;251-258.
26. Alvarez R D, Potter M E, Soong S J, Gay F L, Hatch K D, Partridge E E, Shingleton H M. Rationale for using pathologic tumor dimensions and nodal status to subclassify surgically treated stage IB cervical cancer patients. Gynecology. 43:1991;108-112.
27. Morrow C P. Panel report: is pelvic radiation beneficial in the postoperative management of Stage Ib squamous cell carcinoma of the cervix with pelvic node metastasis treated by radical hysterectomy and pelvic lymphadenectomy? Gynecol Oncol. 10:1980;105-110.
28. Kinney W K, Alvarez R D, Reid G C, Schray M F, Soong S J, Morley G W, Podratz K C, Shingleton H M. Value of adjuvant whole-pelvis irradiation after Wertheim hysterectomy for early-stage squamous carcinoma of the cervix with pelvic node metastasis: a matched-control study. Gynecol Oncol. 34:1989;258-262.
29. Remy J C, di Maio T, Fruchter R G, Sedlis A, Boyce J G, Sohn C K, Rotman M. Adjunctive radiation after radical hysterectomy in stage IB squamous cell carcinoma of the cervix. Gynecol Oncol. 38:1990;161-165.
30. Shingleton H M, Orr J W. Cancer of the cervix. 1995;Lippincott, Philadelphia.